Research identifies cell receptor as target for anti-inflammatory immune response
Monday, December 29, 2008 - 12:41
in Health & Medicine
A common treatment for autoimmune diseases — intravenous immunoglobulin or IVIG — has defied scientific explanation for years. But researchers at The Rockefeller University have homed in on a specialized cell receptor in the immune system that facilitates IVIG's work, suggesting a target for new potential anti-inflammatory agents.